cular disease in those treated with intensive insulin therapy vs conventional therapy during the trial. 8 In the current report, based on 107 deaths among 1429 participants, those randomized to intensive insulin therapy, compared to those randomized to conventional therapy, had lower all-cause mortality (43 deaths vs 64 deaths, respectively; hazard ratio, 0.67 [95% CI, 0.46-0.99], P = .045). The most common causes of death were cardiovascular disease (22%), cancer (20%), and acute complications (18%). Notably, all-cause mortality was significantly
